» Articles » PMID: 32962673

Assessment of the Effect of Platelet Rich Plasma on the Healing of Operated Sacrococcygeal Pilonidal Sinus by Lay-open Technique: a Randomized Clinical Trial

Overview
Journal BMC Surg
Publisher Biomed Central
Specialty General Surgery
Date 2020 Sep 23
PMID 32962673
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sacrococcygeal pilonidal sinus disease (PSD) is an infection of the skin and subcutaneous tissue at the upper part of the natal cleft of the buttocks. Excision and healing by granulation "lay-open" method is still more preferable than other methods of midline closure or using flaps but the healing time is lengthy. The present study was performed to assess the healing promotion effect of platelet-rich plasma (PRP) on the pilonidal sinus wounds treated by the lay-open method.

Methods: One hundred patients suffering from PSD were randomly divided into two groups, they were treated by the lay-open method, at General surgery department, Kafr El-Sheik University hospital, Egypt, during the period from December 2018 to December 2019. Group (A) was adopted the regular dressing postoperatively, while group (B) was treated with PRP injection into the wound at 4 and 12 postoperative days.

Results: Accelerated rate of wound healing was detected in group (B) in day 10, with a significant difference detected in days 15, 20, 25 and 30 postoperative, with a mean time of complete healing 45 ± 2.6 days in group B, while it was 57 ± 2.4 days in group A with a p-value of 0.001 which indicates considerable effect in the treated group.

Conclusions: PRP injection is an effective new technique in accelerating the healing of pilonidal wound after surgery, with a significant decrease in post-operative pain, complications and an early return to work.

Trial Registration: retrospectively registered.

Trial Registration Number: 12/35/1016 issued on December 2018 from the Institution Review Board at Kafr El Sheikh University. ClinicalTrials.gov identifier: NCT04430413.

Citing Articles

The power of platelet-rich plasma on operated pilonidal disease: a prospective randomized controlled trial.

Chousein B, Olcucuoglu E, Kaya I Ann Surg Treat Res. 2025; 108(2):124-134.

PMID: 39944926 PMC: 11813548. DOI: 10.4174/astr.2025.108.2.124.


Platelet-rich plasma treatment for chronic wounds: A case report and literature review.

Dimova A, Boros M, Dimov S, Konjevod J, Svetec M World J Clin Cases. 2024; 12(33):6635-6643.

PMID: 39600480 PMC: 11514336. DOI: 10.12998/wjcc.v12.i33.6635.


Systematic Review of Platelet-Rich Plasma in Medical and Surgical Specialties: Quality, Evaluation, Evidence, and Enforcement.

Rahman E, Rao P, Abu-Farsakh H, Thonse C, Ali I, Upton A J Clin Med. 2024; 13(15).

PMID: 39124838 PMC: 11313071. DOI: 10.3390/jcm13154571.


Platelet-rich plasma for pilonidal disease: a systematic review.

Zhuang Y, Feng W J Int Med Res. 2023; 51(12):3000605231216590.

PMID: 38141657 DOI: 10.1177/03000605231216590.


Current status of platelet-rich plasma therapy under the act on the safety of regenerative medicine in Japan.

Arita A, Tobita M Regen Ther. 2023; 23:37-43.

PMID: 37063096 PMC: 10090952. DOI: 10.1016/j.reth.2023.03.001.


References
1.
Spyridakis M, Christodoulidis G, Chatzitheofilou C, Symeonidis D, Tepetes K . The role of the platelet-rich plasma in accelerating the wound-healing process and recovery in patients being operated for pilonidal sinus disease: preliminary results. World J Surg. 2009; 33(8):1764-9. DOI: 10.1007/s00268-009-0046-y. View

2.
Ferrara N, Henzel W . Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989; 161(2):851-8. DOI: 10.1016/0006-291x(89)92678-8. View

3.
Redler L, Thompson S, Hsu S, Ahmad C, Levine W . Platelet-rich plasma therapy: a systematic literature review and evidence for clinical use. Phys Sportsmed. 2011; 39(1):42-51. DOI: 10.3810/psm.2011.02.1861. View

4.
Veevers-Lowe J, Ball S, Shuttleworth A, Kielty C . Mesenchymal stem cell migration is regulated by fibronectin through α5β1-integrin-mediated activation of PDGFR-β and potentiation of growth factor signals. J Cell Sci. 2011; 124(Pt 8):1288-300. PMC: 3065385. DOI: 10.1242/jcs.076935. View

5.
Oncel M, Kurt N, Kement M, Colak E, Eser M, Uzun H . Excision and marsupialization versus sinus excision for the treatment of limited chronic pilonidal disease: a prospective, randomized trial. Tech Coloproctol. 2003; 6(3):165-9. DOI: 10.1007/s101510200037. View